Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke

被引:246
作者
Chamorro, A
Obach, V
Cervera, A
Revilla, M
Deulofeu, R
Aponte, JH
机构
[1] Hosp Clin Barcelona, Neurol Serv, Barcelona 08036, Spain
[2] Hosp Clin Barcelona, IDIBAPS, Dept Biochem & Chromatog, Barcelona 08036, Spain
[3] Hosp Clin Barcelona, Dept Epidemiol & Biostat, Barcelona 08036, Spain
关键词
antioxidants; cerebrovascular disorders; outcome; uric acid;
D O I
10.1161/hs0402.105927
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-We sought to assess in 881 consecutive patients with acute ischemic stroke the clinical a relevance in regard to functional outcome of the natural antioxidant uric acid measured at hospital admission. Methods-Patients had serum uric acid (mg/dL) measured by standard procedures 18.2+/-15.5 hours from clinical onset. At hospital discharge (11.0+/-6.0-days), neurological impairment was classified as moderate/severe (Mathew score less than or equal to75; n=304) or mild/absent (Mathew score >75; n=577). Demographics, atherosclerotic risk factors, history of organ disease, baseline neurological score, stroke subtype, infarction size, renal function, aspirin use before stroke, stroke therapy, diuretic use, and laboratory markers, including erythrocyte sedimentation rate, were analyzed in both outcome groups with the use of backward logistic regression. Results-increased uric acid values were found in men, hypertensives, alcohol drinkers, and patients with coronary, pulmonary, or renal diseases. Diabetic patients had lower uric acid levels on admission. Uric acid was directly associated with hematocrit (P=0.001), sodium (P=0.001), creatinine (P=0.001), and triglycerides (P=0.001) and inversely related with nonfasting glucose (P=0.001) levels. Neurological impairment on admission (P=0.001) and final infarction size on CT/MRI (P=0.01) were also inversely associated with uric acid. A logistic regression adjusted for confounders confirmed the following independent (odds ratio, 95% CI) good outcome predictors: age (0.97, 0.96 to 0.99), Mathew score on admission (1.14, 1.12 to 1.17), erythrocyte sedimentation rate (0.98, 0.97 to 0.99), infarction volume (0.98, 0.98 to 0.99), and uric acid (1.12, 1.00 to 1.25). Conclusions-In patients with acute ischemic stroke, there is a 12% increase in the odds of good clinical outcome for each milligram per deciliter increase of serum uric acid. This finding reinforces the relevance of oxidative damage in ischemic stroke.
引用
收藏
页码:1048 / 1052
页数:5
相关论文
共 31 条
  • [11] URIC-ACID IRON-ION COMPLEXES - A NEW ASPECT OF THE ANTIOXIDANT FUNCTIONS OF URIC-ACID
    DAVIES, KJA
    SEVANIAN, A
    MUAKKASSAHKELLY, SF
    HOCHSTEIN, P
    [J]. BIOCHEMICAL JOURNAL, 1986, 235 (03) : 747 - 754
  • [12] CONVERSION OF XANTHINE DEHYDROGENASE TO OXIDASE IN ISCHEMIC RAT-TISSUES
    ENGERSON, TD
    MCKELVEY, TG
    RHYNE, DB
    BOGGIO, EB
    SNYDER, SJ
    JONES, HP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (06) : 1564 - 1570
  • [13] RELATION OF SERUM URIC-ACID TO MORTALITY AND ISCHEMIC-HEART-DISEASE - THE NHANES-I EPIDEMIOLOGIC FOLLOW-UP-STUDY
    FREEDMAN, DS
    WILLIAMSON, DF
    GUNTER, EW
    BYERS, T
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (07) : 637 - 644
  • [14] NEUROLOGICAL SCALES IN THE ASSESSMENT OF CEREBRAL INFARCTION
    HANTSON, L
    DEKEYSER, J
    [J]. CEREBROVASCULAR DISEASES, 1994, 4 : 7 - 14
  • [15] IRIBARREN C, 1999, STROKE, V29, P635
  • [16] JARASCH ED, 1986, ACTA PHYSIOL SCAND, V126, P39
  • [17] XANTHINE AND URIC-ACID LEVELS IN RAT-BRAIN FOLLOWING FOCAL ISCHEMIA
    KANEMITSU, H
    TAMURA, A
    KIRINO, T
    KARASAWA, S
    SANO, K
    IWAMOTO, T
    YOSHIURA, M
    IRIYAMA, K
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 51 (06) : 1882 - 1885
  • [18] CHANGES IN XANTHINE-OXIDASE IN ISCHEMIC RAT-BRAIN
    KINUTA, Y
    KIMURA, M
    ITOKAWA, Y
    ISHIKAWA, M
    KIKUCHI, H
    [J]. JOURNAL OF NEUROSURGERY, 1989, 71 (03) : 417 - 420
  • [19] IS THIAZIDE-PRODUCED URIC-ACID ELEVATION HARMFUL - ANALYSIS OF DATA FROM THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM
    LANGFORD, HG
    BLAUFOX, MD
    BORHANI, NO
    CURB, JD
    MOLTENI, A
    SCHNEIDER, KA
    PRESSEL, S
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (04) : 645 - 649
  • [20] LEHTO S, 1996, ANN EPIDEMIOL, V6, P331